CST3 and atherosclerosis: As an endogenous inhibitor cystatin C, promising biomarkers in the diagnosis of coronary artery disease, it may favor proteolysis of extracellular matrix (ECM) in the pathogenesis of ASCVD by participating in inflammation and extracellular matrix remodeling [32].